Switch to:
More From Other Websites
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 19 2014
THERAVANCE INC Financials Nov 14 2014
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Nov 13 2014
Theravance Biopharma to Present at the Stifel Healthcare Conference on November 18th Nov 12 2014
Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat Nov 10 2014
10-Q for Theravance, Inc. Nov 06 2014
Theravance Biopharma, Inc. Reports Third Quarter 2014 Financial Results Nov 06 2014
Theravance to Present at Two Upcoming Investor Conferences in November Nov 05 2014
THERAVANCE INC Files SEC form 10-Q, Quarterly Report Nov 04 2014
Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 Nov 03 2014
Theravance misses Street 3Q forecasts Oct 31 2014
Theravance misses Street 3Q forecasts Oct 31 2014
Theravance Biopharma, Inc. to Report Third Quarter 2014 Financial Results on November 6, 2014 Oct 30 2014
THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition Oct 30 2014
Theravance Reports Third Quarter 2014 Financial Results Oct 30 2014
Q3 2014 Theravance Inc Earnings Release - After Market Close Oct 30 2014
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 28 2014
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 27 2014
Theravance to Report Third Quarter 2014 Financial Results on October 30, 2014 Oct 23 2014
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Oct 21 2014
Theravance (THRX) In A Perilous Reversal Oct 17 2014
THERAVANCE INC Files SEC form 8-K, Other Events Oct 17 2014
Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function Compared to Tiotropium Oct 17 2014
THERAVANCE INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 09 2014
Theravance, Inc. Appoints Eric d'Esparbes as Senior Vice President and Chief Financial Officer Oct 09 2014
THERAVANCE INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 19 2014
Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia Apr 30 2014
Theravance to Present at the 13th Annual Needham Healthcare Conference Mar 26 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With... Mar 14 2014
GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with... Mar 14 2014
Theravance Announces Update to Planned Separation of Late-Stage Partnered Respiratory Assets from... Mar 03 2014
Theravance to Present at Investor Conferences in March 2014 Feb 25 2014
Anoro(R) (umeclidinium / vilanterol) Receives Positive Opinion From the CHMP in Europe for the... Feb 20 2014
Theravance Reports 2013 Financial Results Feb 06 2014
Theravance to Present at the Leerink Global Healthcare Conference Jan 30 2014
Theravance Appoints Frank Pasqualone Senior Vice President, Operations Jan 23 2014
Theravance to Report Fourth Quarter and Full Year 2013 Financial Results on February 6, 2014 Jan 22 2014
Theravance to Present at the 32nd Annual J.P. Morgan Healthcare Conference Jan 09 2014
ANORO(TM) ELLIPTA(TM) Approved as First Once-Daily Dual Bronchodilator for the Treatment of COPD in... Dec 18 2013
ANORO™ ELLIPTA™ approved as first once-daily dual bronchodilator for the treatment of COPD in... Dec 18 2013
FDA approves ANORO ELLIPTA Dec 18 2013
FDA approves another GSK, Theravance lung drug Dec 18 2013
GSK and Theravance announce positive results from pivotal phase III study for fluticasone... Dec 06 2013
GSK, Theravance asthma drug shows improved lung function in study Dec 06 2013
Irish biotech firm Elan signs $1.0-bn US deal May 13 2013


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK